We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.59%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$840M
AUM Growth
+$124M
(+17%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
13.21%
Top 10 Holdings %
Top 10 Hldgs %
40.57%
Holding
336
New
86
Increased
109
Reduced
60
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$51.2M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$49.7M |
| 3 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$9.02M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.43M |
| 5 |
Apple
AAPL
|
+$5.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$56.2M |
| 2 |
SPDR Gold Trust
GLD
|
+$53.1M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$53M |
| 4 |
XL
XL Group Ltd.
XL
|
+$4.42M |
| 5 |
Vanguard Total Bond Market
BND
|
+$4.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.45% |
| 2 | Healthcare | 7.07% |
| 3 | Industrials | 4.36% |
| 4 | Financials | 4.13% |
| 5 | Communication Services | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
151
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.11M | 0.13% |
+103,000
| New | +$1.1M |
|
152
Citizens Financial Group
CFG
$30.4B
| $1.1M | 0.13% |
+55,227
| New | +$1.23M |
|
153
American Express
AXP
$239B
| $1.09M | 0.13% |
17,903
+1,034
| +6% | +$65.5K |
|
154
Ocular Therapeutix
OCUL
$1.96B
| $1.09M | 0.13% |
219,752
| – | – |
|
155
General Dynamics
GD
$99.4B
| $1.07M | 0.13% |
7,722
-69
| -0.9% | -$9.62K |
|
|
DISH
156
DELISTED
DISH Network Corp.
DISH
| $1.02M | 0.12% |
19,449
-135
| -0.7% | -$6.6K |
|
|
NBSE
157
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1M | 0.12% |
913
| – | – |
|
158
iShares Select Dividend ETF
DVY
$23.7B
| $980K | 0.12% |
11,489
| – | – |
|
|
HDV
159
iShares Core High Dividend ETF
HDV
$14.2B
| $947K | 0.11% |
57,675
+1,575
| +3% | +$25.1K |
|
160
State Street SPDR S&P Dividend ETF
SDY
$21.6B
| $943K | 0.11% |
11,241
| – | – |
|
161
Berkshire Hathaway Class B
BRK.B
$1.06T
| $938K | 0.11% |
6,477
+2,832
| +78% | +$405K |
|
162
Travelers Companies
TRV
$81.6B
| $871K | 0.1% |
+7,320
| New | +$828K |
|
163
Fidelity MSCI Energy Index ETF
FENY
$1.99B
| $867K | 0.1% |
44,700
| – | – |
|
|
AGEN
164
Agenus
AGEN
$232M
| $863K | 0.1% |
10,852
| – | – |
|
165
Schwab US REIT ETF
SCHH
$11.6B
| $861K | 0.1% |
39,630
+14,130
| +55% | +$292K |
|
166
Pfizer
PFE
$142B
| $842K | 0.1% |
25,204
+11,373
| +82% | +$363K |
|
167
Compañía de Minas Buenaventura
BVN
$7.94B
| $839K | 0.1% |
+70,200
| New | +$680K |
|
168
iShares Russell 2000 ETF
IWM
$82.4B
| $839K | 0.1% |
7,293
+754
| +12% | +$85.1K |
|
169
PepsiCo
PEP
$184B
| $838K | 0.1% |
7,908
+4,238
| +115% | +$437K |
|
170
McDonald's
MCD
$188B
| $791K | 0.09% |
6,575
+2,539
| +63% | +$318K |
|
171
Nike
NKE
$63.7B
| $775K | 0.09% |
14,048
+4,393
| +45% | +$250K |
|
172
Arbutus Biopharma
ABUS
$893M
| $748K | 0.09% |
215,000
| – | – |
|
|
IMMU
173
DELISTED
Immunomedics Inc
IMMU
| $731K | 0.09% |
315,000
| – | – |
|
174
RTX Corp
RTX
$261B
| $719K | 0.09% |
11,142
+531
| +5% | +$34K |
|
175
Trane Technologies
TT
$104B
| $719K | 0.09% |
11,290
+1,542
| +16% | +$99.2K |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q2 2016 Portfolio in Review
As of Q2 2016, Bailard held 336 positions worth $840M, up 17% from $717M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Bailard deployed $111M of net new capital in Q2 2016, opening 86 new positions and adding to 109 existing holdings. Its largest new stake was iShares Intermediate Government/Credit Bond ETF: 80,477 shares worth $9.12M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $53.1M trimmed.
- Bailard's largest Q2 2016 buy was iShares Intermediate Government/Credit Bond ETF: 80,477 shares worth $9.12M.
- Bailard added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $51.2M increase.
- Bailard's biggest Q2 2016 reduction was SPDR Gold Trust, cutting an estimated $53.1M.
- Bailard fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2016, selling an estimated $56.2M.
- Bailard's ten largest holdings make up 41% of its $840M portfolio in Q2 2016.
- Bailard opened 86 new positions and closed 39 in Q2 2016.
- Bailard's portfolio value rose 17% quarter-over-quarter to $840M.
Based on Bailard's 13F filing for Q2 2016, filed 8 Aug 2016.